Literature DB >> 19664365

Immunologically mediated dementias.

Michael H Rosenbloom1, Sallie Smith, Gulden Akdal, Michael D Geschwind.   

Abstract

Although most dementias are due to neurodegenerative or vascular disease, it is important to diagnose immunologically mediated dementias quickly because they can be both rapidly progressive and readily treatable. They usually affect function of limbic and cortical structures, but subcortical involvement can also occur. Because of the variety of symptoms and the rapid course, these dementias present a particular challenge to the clinician and may require evaluation and intervention in the inpatient setting. Diagnostic workup typically reveals evidence of an autoimmune process and, in some cases, cancer. In contrast to the neurodegenerative processes, many of the immunologically mediated dementias respond to immunomodulatory therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664365      PMCID: PMC2832614          DOI: 10.1007/s11910-009-0053-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  55 in total

1.  Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.

Authors:  L Bataller; K A Kleopa; G F Wu; J E Rossi; M R Rosenfeld; J Dalmau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

2.  Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease.

Authors:  Chiung-Chih Chang; Scott D Eggers; Julene K Johnson; Aissa Haman; Bruce L Miller; Michael D Geschwind
Journal:  Clin Neurol Neurosurg       Date:  2006-04-18       Impact factor: 1.876

3.  Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I.

Authors:  Armin Alaedini; Haruka Okamoto; Chiara Briani; Kurt Wollenberg; Holly A Shill; Khalafalla O Bushara; Howard W Sander; Peter H R Green; Mark Hallett; Norman Latov
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

4.  Cognitive impairment and celiac disease.

Authors:  William T Hu; Joseph A Murray; Melanie C Greenaway; Joseph E Parisi; Keith A Josephs
Journal:  Arch Neurol       Date:  2006-10

5.  Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies.

Authors:  S R Samarasekera; A Vincent; J L Welch; M Jackson; P Nichols; T D Griffiths
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154

Review 6.  Autoimmune encephalopathies.

Authors:  Steven Vernino; Michael Geschwind; Bradley Boeve
Journal:  Neurologist       Date:  2007-05       Impact factor: 1.398

Review 7.  Gluten ataxia: passive transfer in a mouse model.

Authors:  Sabrina Boscolo; Alessandra Sarich; Andrea Lorenzon; Monica Passoni; Veronica Rui; Marco Stebel; Daniele Sblattero; Roberto Marzari; Marios Hadjivassiliou; Enrico Tongiorgi
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

8.  Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome.

Authors:  Andrew McKeon; Michael Marnane; Martin O'connell; John P Stack; Peter J Kelly; Timothy Lynch
Journal:  Arch Neurol       Date:  2007-10

Review 9.  The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto's encephalopathy (recurrent acute disseminated encephalomyelitis).

Authors:  Abhijit Chaudhuri; Peter O Behan
Journal:  Curr Med Chem       Date:  2003-10       Impact factor: 4.530

Review 10.  Limbic encephalitis and variants: classification, diagnosis and treatment.

Authors:  Erdem Tüzün; Josep Dalmau
Journal:  Neurologist       Date:  2007-09       Impact factor: 1.398

View more
  8 in total

Review 1.  The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research.

Authors:  Kalyani Kansal; David J Irwin
Journal:  Psychiatr Clin North Am       Date:  2015-03-18

Review 2.  Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis.

Authors:  B P Kelley; S C Patel; H L Marin; J J Corrigan; P D Mitsias; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

3.  Ethics in prion disease.

Authors:  Kendra Bechtel; Michael D Geschwind
Journal:  Prog Neurobiol       Date:  2013-07-29       Impact factor: 11.685

4.  Diagnosis and treatment of rapidly progressive dementias.

Authors:  Ross W Paterson; Leonel T Takada; Michael D Geschwind
Journal:  Neurol Clin Pract       Date:  2012-09

Review 5.  Diagnosis and evaluation of a patient with rapidly progressive dementia.

Authors:  Robert C Bucelli; Beau M Ances
Journal:  Mo Med       Date:  2013 Sep-Oct

6.  Social Engagement and Its Change are Associated with Dementia Risk among Chinese Older Adults: A Longitudinal Study.

Authors:  Zi Zhou; Ping Wang; Ya Fang
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

Review 7.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

8.  Rapidly progressive dementia due to neurosarcoidosis.

Authors:  Gabriela Carneiro C Fortes; Marcos Castello B Oliveira; Laura Cardia G Lopes; Camila S Tomikawa; Leandro T Lucato; Luiz Henrique M Castro; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2013 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.